These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30289407)

  • 1. Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330.
    Kraft L; Roe SM; Gill R; Atack JR
    Acta Crystallogr D Struct Biol; 2018 Oct; 74(Pt 10):973-978. PubMed ID: 30289407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy.
    Gill R; Mohammed F; Badyal R; Coates L; Erskine P; Thompson D; Cooper J; Gore M; Wood S
    Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):545-55. PubMed ID: 15858264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
    Atack JR; Prior AM; Fletcher SR; Quirk K; McKernan R; Ragan CI
    J Pharmacol Exp Ther; 1994 Jul; 270(1):70-6. PubMed ID: 8035344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inositol monophosphatase inhibitors--lithium mimetics?
    Atack JR
    Med Res Rev; 1997 Mar; 17(2):215-24. PubMed ID: 9057165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inositol monophosphatase, the putative therapeutic target for lithium.
    Atack JR
    Brain Res Brain Res Rev; 1996 Aug; 22(2):183-90. PubMed ID: 8883919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calbindin D28k and S100B have a similar interaction site with the lithium-inhibitable enzyme inositol monophosphatase-1: a new drug target site.
    Agam G; Almog O
    J Med Chem; 2015 Feb; 58(4):2042-4. PubMed ID: 25665147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.
    Atack JR; Broughton HB; Pollack SJ
    Trends Neurosci; 1995 Aug; 18(8):343-9. PubMed ID: 7482796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR.
    Haimovich A; Eliav U; Goldbourt A
    J Am Chem Soc; 2012 Mar; 134(12):5647-51. PubMed ID: 22384802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and mechanism of inositol monophosphatase.
    Atack JR; Broughton HB; Pollack SJ
    FEBS Lett; 1995 Mar; 361(1):1-7. PubMed ID: 7890024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural elucidation of the binding site and mode of inhibition of Li(+) and Mg(2+) in inositol monophosphatase.
    Dutta A; Bhattacharyya S; Dutta D; Das AK
    FEBS J; 2014 Dec; 281(23):5309-24. PubMed ID: 25263816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inositol monophosphatase inhibitor L-690,330 affects pilocarpine-behavior and the forced swim test.
    Shtein L; Toker L; Bersudsky Y; Belmaker RH; Agam G
    Psychopharmacology (Berl); 2013 Jun; 227(3):503-8. PubMed ID: 23344554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330.
    Atack JR; Cook SM; Watt AP; Fletcher SR; Ragan CI
    J Neurochem; 1993 Feb; 60(2):652-8. PubMed ID: 8380439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure and catalytic mechanism of the MJ0109 gene product: a bifunctional enzyme with inositol monophosphatase and fructose 1,6-bisphosphatase activities.
    Johnson KA; Chen L; Yang H; Roberts MF; Stec B
    Biochemistry; 2001 Jan; 40(3):618-30. PubMed ID: 11170378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of inositol monophosphatase.
    Fauroux CM; Freeman S
    J Enzyme Inhib; 1999; 14(2):97-108. PubMed ID: 10445037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy.
    Patel S; Yenush L; Rodríguez PL; Serrano R; Blundell TL
    J Mol Biol; 2002 Jan; 315(4):677-85. PubMed ID: 11812139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased inositol-monophosphatase activity by lithium treatment in bipolar patients.
    Kaya N; Resmi H; Ozerdem A; Guner G; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):521-7. PubMed ID: 15093960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression, purification, crystallization and X-ray analysis of inositol monophosphatase from Mus musculus and Homo sapiens.
    Singh N; Halliday AC; Knight M; Lack NA; Lowe E; Churchill GC
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1149-52. PubMed ID: 23027737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of inositol monophosphatase (IMPase) at the calbindin-D28k binding site: molecular and behavioral aspects.
    Levi I; Eskira Y; Eisenstein M; Gilon C; Hoffman A; Tal-Gan Y; Fanous J; Bersudsky Y; Belmaker RH; Agam G; Almog O
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1806-15. PubMed ID: 23619164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional changes in rat brain inositol monophosphatase 1 (IMPase 1) activity with chronic lithium treatment.
    Parthasarathy LK; Seelan RS; Wilson MA; Vadnal RE; Parthasarathy RN
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):55-60. PubMed ID: 12551726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.